Tolerance and autoimmunity in the eye

眼睛的耐受性和自身免疫性

基本信息

  • 批准号:
    7009207
  • 负责人:
  • 金额:
    $ 32.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-01-01 至 2007-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Autoimmune uveitis is a sight threatening autoimmune disease affecting some 20/100,000 people per year. Like other autoimmune diseases, uveitis appears to result form the aberrant activation of T cells toward self antigen present within the eye. How the T cells become activated, and the mechanism of autoimmune tissue destruction is poorly understood. In mice, experimental autoimmune uveitis (EAU) can be induced by immunization with the retinal antigen, interphotoreceptor retinol binding protein (IRBP). This laboratory has optimized the production of human recombinant IRBP, and will use this to probe the nature of the IRBP specific T cells which mediate EAU. One of the fundamental processes in T cell activation is the interaction of the T cell with the antigen presenting cell, yet nothing is known about how this interaction affects EAU in vivo. In the first aim, the role of the antigen presenting cell in the priming and effector function of the IRBP specific T cell will be studied. This will be accomplished through in vivo modulation of APC function and adoptive transfer studies. These experiments will answer important questions regarding how the autoreactive T cell becomes activated, and the nature of the antigen presenting cell within the eye itself which is responsible for T cell effector function. While the transfer of EAU into na?ve mice with IRBP specific T cells has been demonstrated, the nature of the T cell that is capable of inducing disease is not known. In the second aim, a panel of IRBP specific T cell clones will be characterized for a variety of functional properties, as well as their ability to transfer EAU to normal mice. In the third aim, T cell receptor genes from select clones will be isolated and used to produce transgenic mice. These mice will provide a valuable new model system in which to further study the mechanism of EAU. Toward this aim, we will also further develop a transgenic model system in which ovalbumin is expressed in the retina. This will involve the production of new transgenic mice which express a form of ovalbumin which will be retained within the retina, rather than being secreted. Together, these studies will provide important new information as well as produce a new model system resulting in much greater understanding of the mechanisms of autoimmune uveitis.
描述(由申请人提供):自身免疫性葡萄膜炎是一种威胁视力的自身免疫性疾病,每年影响约20/100,000人。与其他自身免疫性疾病一样,葡萄膜炎似乎是由T细胞对眼内存在的自身抗原的异常激活引起的。T细胞如何被激活,以及自身免疫组织破坏的机制知之甚少。在小鼠中,实验性自身免疫性葡萄膜炎(EAU)可以通过用视网膜抗原、光感受器间视黄醇结合蛋白(IRBP)免疫来诱导。本实验室已优化了人重组IRBP的生产,并将利用其来探测介导EAU的IRBP特异性T细胞的性质。T细胞活化的基本过程之一是T细胞与抗原呈递细胞的相互作用,但对这种相互作用如何影响体内EAU一无所知。在第一个目标中,将研究抗原呈递细胞在IRBP特异性T细胞的引发和效应子功能中的作用。这将通过APC功能的体内调节和过继转移研究来实现。这些实验将回答有关自身反应性T细胞如何被激活的重要问题,以及眼睛内负责T细胞效应器功能的抗原递呈细胞的性质。而转移到纳EAU?尽管已经证实了具有IRBP特异性T细胞的小鼠,但是能够诱导疾病的T细胞的性质尚不清楚。在第二个目标中,一组IRBP特异性T细胞克隆将表征各种功能特性,以及它们将EAU转移到正常小鼠的能力。在第三个目标中,将从选择的克隆中分离T细胞受体基因并用于产生转基因小鼠。这些小鼠为进一步研究EAU的发病机制提供了一个有价值的新模型体系。为了实现这一目标,我们还将进一步开发一种转基因模型系统,其中卵清蛋白在视网膜中表达。这将涉及生产新的转基因小鼠,这些小鼠表达一种卵清蛋白,这种卵清蛋白将保留在视网膜内,而不是分泌。总之,这些研究将提供重要的新信息,以及产生一个新的模型系统,从而更好地了解自身免疫性葡萄膜炎的机制。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Reduced T cell-dependent humoral immune response in microsomal prostaglandin E synthase-1 null mice is mediated by nonhematopoietic cells.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jerold G Woodward其他文献

Unfolded Von Willebrand Factor Interacts with Protein S and Limits Its Anticoagulant Activity
  • DOI:
    10.1182/blood-2022-162612
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Martha MS Sim;Hammodah Alfar;Melissa Hollifield;Dominic W. Chung;Xiaoyun Fu;Meenakshi Banerjee;Chi Peng;Xian Li;Alice Thornton;James Z Porterfield;Jamie Sturgill;Gail A Sievert;Marietta Barton-Baxter;Kenneth S Campbell;Jerold G Woodward;José A. López;Sidney W Whiteheart;Beth A Garvy;Jeremy P Wood
  • 通讯作者:
    Jeremy P Wood

Jerold G Woodward的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jerold G Woodward', 18)}}的其他基金

Autumn Immunology Conference
秋季免疫学会议
  • 批准号:
    8597789
  • 财政年份:
    2013
  • 资助金额:
    $ 32.36万
  • 项目类别:
Autumn Immunology Conference
秋季免疫学会议
  • 批准号:
    8890919
  • 财政年份:
    2013
  • 资助金额:
    $ 32.36万
  • 项目类别:
Chylomicrons promote intestinal absorption and systemic dissemination of dietary
乳糜微粒促进肠道吸收和膳食的全身传播
  • 批准号:
    8053458
  • 财政年份:
    2010
  • 资助金额:
    $ 32.36万
  • 项目类别:
Autumn Immunology Conference
秋季免疫学会议
  • 批准号:
    8008715
  • 财政年份:
    2010
  • 资助金额:
    $ 32.36万
  • 项目类别:
Autumn Immunology Conference
秋季免疫学会议
  • 批准号:
    8296610
  • 财政年份:
    2010
  • 资助金额:
    $ 32.36万
  • 项目类别:
Autumn Immunology Conference
秋季免疫学会议
  • 批准号:
    8085928
  • 财政年份:
    2010
  • 资助金额:
    $ 32.36万
  • 项目类别:
To produce transgenic mice which express T cell receptors specific for (IRBP).
产生表达特异T细胞受体(IRBP)的转基因小鼠。
  • 批准号:
    7535963
  • 财政年份:
    2008
  • 资助金额:
    $ 32.36万
  • 项目类别:
To produce transgenic mice which express T cell receptors specific for (IRBP).
产生表达特异T细胞受体(IRBP)的转基因小鼠。
  • 批准号:
    7675985
  • 财政年份:
    2008
  • 资助金额:
    $ 32.36万
  • 项目类别:
Tolerance and autoimmunity in the eye
眼睛的耐受性和自身免疫性
  • 批准号:
    6835669
  • 财政年份:
    2003
  • 资助金额:
    $ 32.36万
  • 项目类别:
Tolerance and autoimmunity in the eye
眼睛的耐受性和自身免疫性
  • 批准号:
    6574067
  • 财政年份:
    2003
  • 资助金额:
    $ 32.36万
  • 项目类别:

相似国自然基金

mir-125b在1型糖尿病自身免疫性胰岛炎中的作用及机制研究
  • 批准号:
    30901627
  • 批准年份:
    2009
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Organ-specific autoimmunity resulting from two genetic defects in tolerance
由两种耐受性遗传缺陷引起的器官特异性自身免疫
  • 批准号:
    10341142
  • 财政年份:
    2018
  • 资助金额:
    $ 32.36万
  • 项目类别:
Mucosal Biology: A Fine Balance between Tolerance and Immunity
粘膜生物学:耐受性和免疫之间的良好平衡
  • 批准号:
    8056443
  • 财政年份:
    2011
  • 资助金额:
    $ 32.36万
  • 项目类别:
Apoptotic cells induce tolerance through TRAIL-expressing CD8+ regulatory T cells
凋亡细胞通过表达 TRAIL 的 CD8 调节性 T 细胞诱导耐受
  • 批准号:
    7892840
  • 财政年份:
    2009
  • 资助金额:
    $ 32.36万
  • 项目类别:
Role of ICOS-B7h Regulatory Costimulatory Pathway in Fetomaternal Tolerance
ICOS-B7h 调节共刺激通路在胎儿母体耐受性中的作用
  • 批准号:
    7359526
  • 财政年份:
    2009
  • 资助金额:
    $ 32.36万
  • 项目类别:
Role of ICOS-B7h Regulatory Costimulatory Pathway in Fetomaternal Tolerance
ICOS-B7h 调节共刺激通路在胎儿母体耐受性中的作用
  • 批准号:
    7895887
  • 财政年份:
    2009
  • 资助金额:
    $ 32.36万
  • 项目类别:
Tolerance and autoimmunity in the eye
眼睛的耐受性和自身免疫性
  • 批准号:
    6835669
  • 财政年份:
    2003
  • 资助金额:
    $ 32.36万
  • 项目类别:
Tolerance and autoimmunity in the eye
眼睛的耐受性和自身免疫性
  • 批准号:
    6574067
  • 财政年份:
    2003
  • 资助金额:
    $ 32.36万
  • 项目类别:
Tolerance and autoimmunity in the eye
眼睛的耐受性和自身免疫性
  • 批准号:
    6688971
  • 财政年份:
    2003
  • 资助金额:
    $ 32.36万
  • 项目类别:
MECHANISMS OF TOLERANCE AND AUTOIMMUNITY IN THE EYE
眼部的耐受和自身免疫机制
  • 批准号:
    2608647
  • 财政年份:
    1993
  • 资助金额:
    $ 32.36万
  • 项目类别:
MECHANISMS OF TOLERANCE AND AUTOIMMUNITY IN THE EYE
眼部的耐受和自身免疫机制
  • 批准号:
    2019826
  • 财政年份:
    1993
  • 资助金额:
    $ 32.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了